在心脏血管肉瘤的次要原因中出现的经常性心周溢血
Zahid Khan1,2,3,4
1Acute Medicine, Mid and South Essex NHS Foundation Trust, Southend-on-Sea, GBR.
Cureus
|June 17, 2024
概括
一位年轻的患者经历了反复的心周溢血,诊断为心血管瘤. 及时诊断和涉及心周切割,手术切除和化疗的治疗导致了积极的结果.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
背景情况:
- 心脏血管肉瘤是一种罕见且具有攻击性的恶性瘤,起源于心脏.
- 心周溢出可能是心脏瘤的初始表现,导致吸管.
研究的目的:
- 在年轻人中报告心脏血管瘤病例,呈现为复发性心周输液.
- 突出诊断和治疗的挑战和结果.
主要方法:
- 一个年轻的男性患者的病例介绍,患有类似流感的症状和渐进的呼吸短促.
- 诊断工作包括心声回声,计算机断层扫描和心脏磁共振成像.
- 治疗包括紧急心周切合,手术切除瘤和辅助化疗.
主要成果:
- 最初的表现是巨大的心周溢出和坦波纳德生理学.
- 心脏磁共振成像显示了显著的心周质量.
- 成功的手术切除和化疗被患者容忍得很好.
结论:
- 在年轻患者中,应考虑心脏血管瘤,这些患者有不明原因的复发性心周溢血.
- 多模式成像对于诊断至关重要.
- 积极的手术和化疗管理可以带来有利的结果.
相关概念视频
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
420
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420


